144 related articles for article (PubMed ID: 27570561)
1. The Clinical Significance and Potential Therapeutic Role of GPx3 in Tumor Recurrence after Liver Transplantation.
Qi X; Ng KT; Shao Y; Li CX; Geng W; Ling CC; Ma YY; Liu XB; Liu H; Liu J; Yeung WH; Lo CM; Man K
Theranostics; 2016; 6(11):1934-46. PubMed ID: 27570561
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma.
Qi X; Ng KT; Lian QZ; Liu XB; Li CX; Geng W; Ling CC; Ma YY; Yeung WH; Tu WW; Fan ST; Lo CM; Man K
Oncotarget; 2014 Nov; 5(22):11103-20. PubMed ID: 25333265
[TBL] [Abstract][Full Text] [Related]
3. The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation.
Man K; Lo CM; Xiao JW; Ng KT; Sun BS; Ng IO; Cheng Q; Sun CK; Fan ST
Ann Surg; 2008 Jun; 247(6):1049-57. PubMed ID: 18520234
[TBL] [Abstract][Full Text] [Related]
4. Glutathione Peroxidase 3 Delivered by hiPSC-MSCs Ameliorated Hepatic IR Injury via Inhibition of Hepatic Senescence.
Qi X; Ng KT; Lian Q; Li CX; Geng W; Ling CC; Yeung WH; Ma YY; Liu XB; Liu H; Liu J; Yang XX; Lo CM; Man K
Theranostics; 2018; 8(1):212-222. PubMed ID: 29290803
[No Abstract] [Full Text] [Related]
5. Post-transplant endothelial progenitor cell mobilization via CXCL10/CXCR3 signaling promotes liver tumor growth.
Ling CC; Ng KT; Shao Y; Geng W; Xiao JW; Liu H; Li CX; Liu XB; Ma YY; Yeung WH; Qi X; Yu J; Wong N; Zhai Y; Chan SC; Poon RT; Lo CM; Man K
J Hepatol; 2014 Jan; 60(1):103-9. PubMed ID: 23994383
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
7. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
[TBL] [Abstract][Full Text] [Related]
8. Suppression of hepatocellular carcinoma recurrence after rat liver transplantation by FTY720, a sphingosine-1-phosphate analog.
Ushitora Y; Tashiro H; Ogawa T; Tanimoto Y; Kuroda S; Kobayashi T; Miyata Y; Itamoto T; Asahara T; Ohdan H
Transplantation; 2009 Oct; 88(8):980-6. PubMed ID: 19855243
[TBL] [Abstract][Full Text] [Related]
9. Molecular signature linked to acute phase injury and tumor invasiveness in small-for-size liver grafts.
Man K; Shih KC; Ng KT; Xiao JW; Guo DY; Sun CK; Lim ZX; Cheng Q; Liu Y; Fan ST; Lo CM
Ann Surg; 2010 Jun; 251(6):1154-61. PubMed ID: 20485145
[TBL] [Abstract][Full Text] [Related]
10. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
11. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
Figueras J; Jaurrieta E; Valls C; Benasco C; Rafecas A; Xiol X; Fabregat J; Casanovas T; Torras J; Baliellas C; Ibañez L; Moreno P; Casais L
Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
[TBL] [Abstract][Full Text] [Related]
12. CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation.
Li CX; Ling CC; Shao Y; Xu A; Li XC; Ng KT; Liu XB; Ma YY; Qi X; Liu H; Liu J; Yeung OW; Yang XX; Liu QS; Lam YF; Zhai Y; Lo CM; Man K
J Hepatol; 2016 Nov; 65(5):944-952. PubMed ID: 27245433
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of multislice spiral CT and MRI in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma].
Wang J; He BJ; Jiang ZB; Zhang YQ; Shan H; Xiao R; Zhang JS; Luo L; Kuang SC; Chen GH; Yang Y
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):691-6. PubMed ID: 20021867
[TBL] [Abstract][Full Text] [Related]
15. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
[TBL] [Abstract][Full Text] [Related]
16. Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma.
Cheung ST; Fan ST; Lee YT; Chow JP; Ng IO; Fong DY; Lo CM
Transplantation; 2008 Jan; 85(1):81-7. PubMed ID: 18192916
[TBL] [Abstract][Full Text] [Related]
17. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
Löhe F; Angele MK; Rentsch M; Graeb C; Gerbes A; Löhrs U; Beuers U; Jauch KW
Clin Transplant; 2007; 21(6):696-701. PubMed ID: 17988261
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathway.
Geng W; Lo CM; Ng KT; Ling CC; Qi X; Li CX; Zhai Y; Liu XB; Ma YY; Man K
Oncotarget; 2015 Sep; 6(29):28042-56. PubMed ID: 26336986
[TBL] [Abstract][Full Text] [Related]
19. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation.
Kim PT; Onaca N; Chinnakotla S; Davis GL; Jennings LW; McKenna GJ; Ruiz RM; Levy MF; Goldstein R; Klintmalm GB
Clin Transplant; 2013; 27(2):311-8. PubMed ID: 23351129
[TBL] [Abstract][Full Text] [Related]
20. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
